1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: Other
Protocol IDs: PCI-9404, NCI-V94-0494
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 56 and over
Sponsor: NCI
Protocol IDs: SWOG-9333
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0060-002, NCI-V95-0712
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI
Protocol IDs: COG-D9602, CCG-D9602, POG-D9602, IRS-D9602, D9602, NCT00002995
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 21
Sponsor: NCI
Protocol IDs: COG-A3961, CCG-A3961, POG-A3961, NCT00003093, A3961
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 21
Sponsor: NCI
Protocol IDs: COG-P9641, POG-P9641, CCG-P9641, NCT00003119, P9641
|
|
11.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MRC-LEUK-IFI, EU-97030, NCT00003315
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI
Protocol IDs: COG-D9803, CCG-D9803, POG-D9803, IRS-D9803, NCT00003958, D9803
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067568, U10CA021115, ECOG-4697, SWOG-E4697, E4697, NCT00005034
|
|
14.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: RTOG-9901, NCI-P00-0177, NCT00008398
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENITOPE-G2000-03, CUMC-0101-142, UCLA-0010061, NCT00017290
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8229/30, SWOG-8230
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 10 to 60
Sponsor:
Protocol IDs: EORTC-06863
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 45 to 60
Sponsor: Other
Protocol IDs: EORTC-06864, NCT01324063
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15 to less than 65
Sponsor:
Protocol IDs: MSKCC-88108, NCI-V88-0644
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15 to less than 65
Sponsor:
Protocol IDs: GUMC-14088, NCI-V89-0065
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8812
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: NCI
Protocol IDs: CLB-8923, CALGB-8923
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: AECM-8903071, NCI-V89-0161
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: UW-C89-049-05, NCI-V89-0252
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 55 to 70
Sponsor: NCI
Protocol IDs: EST-1490
|
Mobile | Español
